Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19-Reference-Cited by-同舟云学术

Nasal ciliated cells are primary targets for SARS-CoV-2 replication in the early stage of COVID-19

Published:2021-07-01 Issue:13 Volume:131 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Ahn Ji Hoon^ORCID,Kim JungMo,Hong Seon Pyo^ORCID,Choi Sung Yong,Yang Myung Jin,Ju Young Seok,Kim Young Tae^ORCID,Kim Ho Min^ORCID,Rahman MD Tazikur,Chung Man Ki,Hong Sang Duk,Bae Hosung^ORCID,Lee Chang-Seop,Koh Gou Young

Funder

Institute for Basic Science and National Research Foundation of Korea

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/148517/files/pdf

Reference51 articles.

1. The trinity of COVID-19: immunity, inflammation and intervention

2. Extrapulmonary manifestations of COVID-19

3. SARS-CoV-2 productively infects human gut enterocytes

4. Mild or Moderate Covid-19

5. Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals

Cited by 198 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 3D-printed airway model as a platform for SARS-CoV-2 infection and antiviral drug testing;Biomaterials;2024-12

2. SUB-immunogold-SEM reveals nanoscale distribution of submembranous epitopes;Nature Communications;2024-09-10

3. Resistance to SARS-CoV-2 infection in camelid nasal organoids is associated with lack of ACE2 expression;npj Viruses;2024-09-02

4. COVID-19 in Pediatric Populations;Clinics in Chest Medicine;2024-09

5. Cellular response in the pathogenesis of COVID-19;COVID-19: An Update;2024-09-01